Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 25, 2003

View Archived Issues

BMP-7 implants in lumbar fusion

Potential role for antileukotriene agents in the treatment of late-stage atherosclerosis

No association found for inhaled corticosteroids and a lower BMD in postmenopausal women

NPS and Enzon agree to merger of equals

Novo Nordisk claims new purine-based DPP-IV inhibitors

Novel chemokine CCR3 modulators and their use in asthma and rhinitis

Vertex scientists design novel inhibitors of Src and/or Lck kinases

Novel DPP-IV inhibitors in early development at Merck

New erythromycin antibiotics prepared and tested at Chiron

Alphav integrin antagonists and their use disclosed by 3DP

Active Biotech presents new immunomodulators targeting the CD80/CD28 interaction

NeuroSearch describes modulators of nicotinic receptors and/or monoamine transporters

Advexin awarded orphan drug designation

Biopure receives additional funding to develop Hemopure for trauma applications

Results from phase III Surfaxin trial will be delayed several months

Enrollment temporarily suspended in phase III studies of tariquidar

Promising results reported for Targretin in chronic severe hand dermatitis

KS Biomedix reviews half-year milestones

Ono-4817 plus docetaxel inhibits lung micrometastasis of MMP-expressing tumor cells in nude mice

SB-203580 induces p38 MAP kinase-independent differentiation of leukemia cells

AVI-4126 increases sensitivity of lung tumors to conventional chemotherapeutic agents

New antiinflammatory role proposed for statins

Nonthiazolidinedine antidiabetic agent with favorable pharmacological and pharmacokinetic profile

First Chugai product licensed by Roche for codevelopment/copromotion

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...